DE60315685D1 - 6-methylpyridinderivat, verfahren zu seiner herstellung und es enthaltende antivirale pharmazeutische zusammensetzung - Google Patents
6-methylpyridinderivat, verfahren zu seiner herstellung und es enthaltende antivirale pharmazeutische zusammensetzungInfo
- Publication number
- DE60315685D1 DE60315685D1 DE60315685T DE60315685T DE60315685D1 DE 60315685 D1 DE60315685 D1 DE 60315685D1 DE 60315685 T DE60315685 T DE 60315685T DE 60315685 T DE60315685 T DE 60315685T DE 60315685 D1 DE60315685 D1 DE 60315685D1
- Authority
- DE
- Germany
- Prior art keywords
- pharmaceutical composition
- preparation
- composition containing
- hepatitis
- antiviral pharmaceutical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR10-2002-0061994A KR100453946B1 (ko) | 2002-10-11 | 2002-10-11 | 6-메틸피리딘 유도체, 그 제조방법 및 이를 포함하는 항바이러스용 약학적 조성물 |
| PCT/KR2003/002034 WO2004033450A1 (en) | 2002-10-11 | 2003-10-02 | 6-methylpyridine derivatives, method for preparing thereof and antiviral pharmaceutical composition comprising the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE60315685D1 true DE60315685D1 (de) | 2007-09-27 |
Family
ID=32089702
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60315685T Expired - Lifetime DE60315685D1 (de) | 2002-10-11 | 2003-10-02 | 6-methylpyridinderivat, verfahren zu seiner herstellung und es enthaltende antivirale pharmazeutische zusammensetzung |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US7244731B2 (de) |
| EP (1) | EP1549642B1 (de) |
| JP (1) | JP2006506358A (de) |
| KR (1) | KR100453946B1 (de) |
| CN (1) | CN100355752C (de) |
| AT (1) | ATE370122T1 (de) |
| AU (1) | AU2003265122B2 (de) |
| BR (1) | BR0314478A (de) |
| CA (1) | CA2499642A1 (de) |
| DE (1) | DE60315685D1 (de) |
| MX (1) | MXPA05003159A (de) |
| WO (1) | WO2004033450A1 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102004050283A1 (de) | 2004-10-15 | 2006-04-27 | Lanxess Deutschland Gmbh | 4-Aminophenyl-morpholinon-Derivate und deren Herstellung |
| AU2008248116A1 (en) | 2007-05-04 | 2008-11-13 | Vertex Pharmaceuticals Incorporated | Combination therapy for the treatment of HCV infection |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2187317B2 (de) * | 1972-06-07 | 1975-06-20 | Hexachimie | |
| US3878206A (en) * | 1973-06-06 | 1975-04-15 | Morton Norwich Products Inc | 9-(Substituted amino)imidazo{8 4,5-f{9 quinolines |
| CA1263378A (en) | 1985-01-08 | 1989-11-28 | Robert James Alaimo | Imidazo¬4,5-f|quinolines useful as immunomodulating agents |
| KR100566193B1 (ko) * | 1999-11-27 | 2006-03-29 | 동화약품공업주식회사 | 신규의 3-니트로피리딘 유도체 및 그를 포함하는 약학적조성물 |
| KR100566194B1 (ko) * | 1999-12-29 | 2006-03-29 | 동화약품공업주식회사 | 신규의 3-니트로피리딘 유도체 및 그를 포함하는 약학적조성물 |
| AU4890301A (en) * | 2000-04-17 | 2001-10-30 | Dong Wha Pharmaceutical Industrial Co., Ltd. | 6-methylnicotinamide derivatives as antiviral agents |
| EP1372654A4 (de) * | 2001-04-06 | 2007-10-03 | Smithkline Beecham Corp | Chinolininhibitoren von hyak1- und hyak3-kinasen |
-
2002
- 2002-10-11 KR KR10-2002-0061994A patent/KR100453946B1/ko not_active IP Right Cessation
-
2003
- 2003-10-02 BR BR0314478-0A patent/BR0314478A/pt not_active IP Right Cessation
- 2003-10-02 MX MXPA05003159A patent/MXPA05003159A/es not_active Application Discontinuation
- 2003-10-02 EP EP03807998A patent/EP1549642B1/de not_active Expired - Lifetime
- 2003-10-02 AT AT03807998T patent/ATE370122T1/de not_active IP Right Cessation
- 2003-10-02 DE DE60315685T patent/DE60315685D1/de not_active Expired - Lifetime
- 2003-10-02 AU AU2003265122A patent/AU2003265122B2/en not_active Ceased
- 2003-10-02 WO PCT/KR2003/002034 patent/WO2004033450A1/en active IP Right Grant
- 2003-10-02 CA CA002499642A patent/CA2499642A1/en not_active Abandoned
- 2003-10-02 US US10/528,461 patent/US7244731B2/en not_active Expired - Fee Related
- 2003-10-02 CN CNB2003801007489A patent/CN100355752C/zh not_active Expired - Fee Related
- 2003-10-02 JP JP2004542896A patent/JP2006506358A/ja not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| US20060269609A1 (en) | 2006-11-30 |
| EP1549642A1 (de) | 2005-07-06 |
| CN1694880A (zh) | 2005-11-09 |
| MXPA05003159A (es) | 2005-06-08 |
| JP2006506358A (ja) | 2006-02-23 |
| EP1549642A4 (de) | 2006-09-20 |
| CN100355752C (zh) | 2007-12-19 |
| KR20040033099A (ko) | 2004-04-21 |
| WO2004033450A1 (en) | 2004-04-22 |
| CA2499642A1 (en) | 2004-04-22 |
| KR100453946B1 (ko) | 2004-10-20 |
| AU2003265122A1 (en) | 2004-05-04 |
| BR0314478A (pt) | 2005-07-26 |
| ATE370122T1 (de) | 2007-09-15 |
| AU2003265122B2 (en) | 2006-11-02 |
| US7244731B2 (en) | 2007-07-17 |
| EP1549642B1 (de) | 2007-08-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2006046039A3 (en) | Tetracyclic indole derivatives as antiviral agents | |
| MY128463A (en) | 4' substituted nucleosides for the treatment of diseases mediated by the hepatitis c virus | |
| NZ610715A (en) | Antiviral compounds and methods | |
| WO2002100415A3 (en) | 4'-substituted nucleosides for the treatment of diseases mediated by the hepatitis c virus | |
| WO2007029029A3 (en) | Tetracyclic indole derivatives as antiviral agents | |
| DK1487829T3 (da) | Thiadizolylpiperazinderivater, der er nyttige til behandling eller forebyggelse af smerte | |
| NO20060981L (no) | Pyridazinderivater og deres anvendelse som terapeutiske midler | |
| DE60215157D1 (de) | Verwendungen von antiviralen nucleosid-derivaten zur herstellung eines medikaments zur behandlung von hepatitis c infektionen | |
| WO2003037860A3 (en) | Purine analogs having hsp90-inhibiting activity | |
| NO20072515L (no) | 2-amido-4-fenyltnazolderivater, fremstilling og terapeutsik anvendelse derav | |
| GEP20104960B (en) | USE OF [D-MeALa]3-[EtVal]4-CYCLOSPORIN FOR THE TREATMENT OF HEPATITIS C INFECTION AND PHARMACEUTICAL COMPOSITION COMPRISING SAID [D-MeAla]3-[EtVal]4-CYCLOSPORIN | |
| NO20011721D0 (no) | N-aralkylaminotetraliner som ligander for neuropeptid Y Y5 reseptor | |
| WO2005007601A3 (en) | Substituted arylthiourea derivatives useful as inhibitors of viral replication | |
| WO2005069933A3 (en) | Methods of treating an inflammatory-related disease | |
| WO2006027628A3 (en) | Naphthalimide derivatives as antiviral agents | |
| WO2005007681A3 (en) | Inhibitors of serine proteases, particularly hcv ns3-ns4a protease | |
| DE602005018972D1 (de) | 5,6-dimethylthienoä2,3-diüpyrimidinderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung für die bekämpfung von viren | |
| WO2004043337A3 (en) | Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides | |
| TNSN02039A1 (en) | RECONSTITUTABLE PARENTERAL COMPOSITION | |
| ATE386725T1 (de) | Heterocyclylverbindungen | |
| WO2001078648A3 (en) | 6-methylnicotinamide derivatives as antiviral agents | |
| WO2001027110A3 (de) | Am sechsring substituierte, bicyclische imidazo-3-yl-aminderivate | |
| GEP20084377B (en) | Agent for inhibiting membrane virus reproduction, method for the production thereof, pharmaceutical composition and method for inhibiting viral infections | |
| MY141506A (en) | Virus therapeutic drug | |
| DE60315685D1 (de) | 6-methylpyridinderivat, verfahren zu seiner herstellung und es enthaltende antivirale pharmazeutische zusammensetzung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8332 | No legal effect for de |